AccessibilityHelpAbout Us
Cann Group logo

Cann Group(OTC) CNGGF

Market Cap$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-99%
1 Year-66%
1 Month-13%
$0.00
+0.00%
+0.00Today
Cann Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-18
Cann Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.79%USD 0.002026-06-09
1 month-12.82%USD 0.002026-04-27
3 month-46.03%USD 0.012026-03-17
Year to date-43.8%USD 0.012025-12-26
1 year-66%USD 0.012025-06-12
3 year-96.83%USD 0.112023-06-13
5 year-98.87%USD 0.302021-06-18
Since inception-99.86%USD 2.432017-12-04

Cann Group Financials at a Glance

Market Cap

$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$21.81M

Net Income (TTM)

-A$2.04M

EPS (TTM)

$0.01

P/E Ratio

0.33

Dividend

$0.00

Beta (Volatility)

8.08 (High)

Price

$0.00

Volume

300

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Feb 26, 2027

CNGGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cann Group

Cann Group Limited specializes in the end-to-end process of bringing medicinal cannabis to market. The company engages in genetic development, cultivation, product manufacturing, clinical trials, and the supply of therapeutic cannabis for both Australian and international markets.

Products and Services
  • Medicinal cannabis products for therapeutic use
  • Research and development in cannabis cultivation and genetics
  • Clinical trials to support product efficacy and safety
Growth Outlook
  • Recent revenue of AUD 4.5 million indicates potential market demand
  • Expansion plans for international export markets are underway
  • Increased focus on R&D may enhance product offerings and market position
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 6.8 million shows growth potential
  • Net income of AUD 26.4 million in the latest quarter reflects operational improvements
  • Current ratio of 0.42 suggests liquidity management challenges
Cann Group Limited operates in the rapidly growing medicinal cannabis sector, which is gaining traction globally. The company's recent revenue figures and net income highlight its potential for growth, particularly as it expands into international markets. The focus on research and development is expected to enhance its product offerings, positioning Cann Group as a competitive player in the industry. However, liquidity management remains a concern, as indicated by the current ratio. Overall, Cann Group Limited presents an intriguing opportunity for investors interested in the evolving landscape of medicinal cannabis.
AI Generated • Aug 24, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Jennifer Lee Pilcher

Website

www.canngrouplimited.com

Headquarters

Mildura, VIC 3501, AU

CNGGF Financials

Key Financial Metrics (TTM)

Gross Margin

-94.13%

Operating Margin

-131.65%

Net Income Margin

237.11%

Return on Equity

64.70%

Return on Capital

-26.44%

Return on Assets

39.05%

Earnings Yield

3.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.66B

Volume

300

Avg. Volume

230.563

Financials (TTM)

Gross Profit

-A$2.90M

Operating Income

-A$20.21M

EBITDA

-A$14.35M

Operating Cash Flow

-A$10.97M

Capital Expenditure

-A$562.53K

Free Cash Flow

-A$11.53M

Cash & ST Invst.

A$489.31K

Total Debt

A$16.82M

Cann Group Performance Analysis

Cann Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 9,267,85099.3%
20242024-06-30AUD 10,075,0808.7%
20252025-06-30AUD 7,318,230-27.4%
20262026-06-30AUD 5,802,485-20.7%
Cann Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-28.5%
Q42025-06-304.9%
Q22025-12-31-33.4%
Q42026-06-30-10.7%
Cann Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.067.4%
20242024-06-30AUD -0.0728.0%
20252025-06-30AUD -0.03-63.0%
20262026-06-30AUD 0.01N/A
Cann Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3173.5%
Q42025-06-309.4%
Q22025-12-31255.9%
Q42026-06-30-146.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$4.04M

-55.3%

Gross Profit

-A$3.60M

-291.6%

Gross Margin

-89.09%

N/A

Market Cap

$5.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$57.61K

N/A

Employees

98

N/A

Net Income

-A$6.07M

+83.6%

EBITDA

-A$2.92M

+45.6%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$489.31K

-70.2%

Total Debt

A$16.82M

-76.8%

Accounts Receivable

A$1.14M

-72.1%

Inventory

A$5.39M

-47.1%

Long Term Debt

A$15.79M

+3650.1%

Short Term Debt

A$1.03M

-98.6%

Return on Assets

39.05%

N/A

Return on Invested Capital

-25.24%

N/A

Free Cash Flow

-A$1.62M

+82.6%

Operating Cash Flow

-A$1.32M

+85.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVTBFAvant Brands Inc.
$0.48-1.02%
RVVTFRevive Therapeutics Ltd.
$0.02-5.91%
LIFDLFTD Partners Inc.
$0.17+70.00%
TGIFF1933 Industries Inc.
$0.00-4.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$104.47+0.09%
NVDANvidia
$225.73-0.02%
ATAIAtaiBeckley
$7.28-0.01%
NOKNokia
$10.65+0.06%

Questions About CNGGF

What is the current price of Cann Group?

Cann Group is trading at $0.00 per share.

What is the 52-week range for Cann Group?

Over the past 52 weeks, Cann Group has traded between $0.00 and $0.02.

How much debt does Cann Group have?

As of the most recent reporting period, Cann Group reported total debt of A$11.67M.

How much cash does Cann Group have on hand?

Cann Group reported A$339.47K in cash and cash equivalents in its most recent financial results.

What is Cann Group’s dividend yield?

Cann Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services